20 results on '"Drugs, Generic adverse effects"'
Search Results
2. In brief: generic celecoxib.
3. Court rules generic drug companies not responsible for adverse outcomes.
4. FDA moves closer to new requirements for NTI drugs.
5. US court rules that patients harmed by generic drugs cannot claim damages.
6. Data exclusivity for biologics.
7. 'Biosimilar' drugs poised to penetrate market.
8. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable].
9. FDA mulls changes to bioequivalence standards.
10. Switches of antiepileptic drug products come under fire.
11. MCC 'tardy' as couple suffer Mefliam 'nightmare'.
12. [Prescribing levothyroxine. Preparation hopping risks accurate regulation].
13. Biotechs go generic: the same but different.
14. [First generic triptan approved].
15. [Hardly any hypoglycemias, constant weight--and still cost effective].
16. Adverse reaction reports may be vulnerable to manipulation.
17. The next biohazard.
18. [Shock reaction caused by tablet color additive. Expert recommend: no generics for allergic patients].
19. ["Critical dose" drugs. Aut-idem could cause problems here].
20. Higher approval standards, consistent practice policies needed for safe use of generic immunosuppressants, say transplant experts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.